Chemoinformaics analysis of Malvidin-3-O-Beta-D-Glucoside
Molecular Weight | 492.433 | nRot | 6 |
Heavy Atom Molecular Weight | 468.241 | nRig | 24 |
Exact Molecular Weight | 492.127 | nRing | 4 |
Solubility: LogS | -3.548 | nHRing | 2 |
Solubility: LogP | 0.191 | No. of Aliphatic Rings | 3 |
Acid Count | 0 | No. of Aromatic Rings | 1 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 1 |
Atoms Count | 59 | No. of Aliphatic Hetero Cycles | 2 |
No. of Heavy Atom | 35 | No. of Aromatic Carbocycles | 1 |
nHetero | 12 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 0 | No. Saturated Carbocycles | 0 |
No. of Hydrogen atom | 24 | No. of Saturated Hetero Cycles | 1 |
No. of Carbon atom | 23 | No. of Saturated Rings | 1 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 16 |
No. of Oxygen atom | 12 | No. of Arom Bond | 16 |
nHA | 12 | APOL | 64.037 |
nHD | 6 | BPOL | 33.625 |
QED | 0.271 |
Synth | 4.186 |
Natural Product Likeliness | 1.652 |
NR-PPAR-gamma | 0.952 |
Lipinski | Rejected |
Pfizer | Accepted |
GSK | Rejected |
Golden Triangle | Accepted |
Pgp-inh | 0.02 |
Pgp-sub | 0.982 |
HIA | 0.844 |
CACO-2 | -6.092 |
MDCK | 0.0000421 |
BBB | 0.217 |
PPB | 0.733839 |
VDSS | 0.923 |
FU | 0.227419 |
CYP1A2-inh | 0.034 |
CYP1A2-sub | 0.143 |
CYP2c19-inh | 0.009 |
CYP2c19-sub | 0.078 |
CYP2c9-inh | 0.006 |
CYP2c9-sub | 0.183 |
CYP2d6-inh | 0.015 |
CYP2d6-sub | 0.242 |
CYP3a4-inh | 0.033 |
CYP3a4-sub | 0.038 |
CL | 6.079 |
T12 | 0.661 |
hERG | 0.058 |
Ames | 0.665 |
ROA | 0.026 |
SkinSen | 0.024 |
Carcinogencity | 0.042 |
EI | 0.008 |
Respiratory | 0.044 |
NR-Aromatase | 0.813 |
Antiviral | Yes |
Prediction | 0.887605 |